RCKT
Rocket Pharmaceuticals Inc
2.60$
-3.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +34.5% | -4.7% | +5.2% | +2.1% | -2.5% | +26.6% | -13.7% | +25.6% | -31.6% | -3.2% | -2.0% | – | |
| – | -3.7% | +3.2% | +10.5% | -0.7% | -1.4% | -6.8% | +5.1% | -10.1% | -37.4% | +39.0% | -12.6% | – | |
| – | – | -121.3% | – | -94.3% | -395.2% | – | – | -231.7% | – | -3,904.6% | – | – | |
| – | -0.2% | -56.2% | -5.2% | -17.7% | -80.5% | +17.8% | -86.3% | +8.0% | +48.1% | +16.3% | -91.4% | – | |
| – | -391.8% | – | +58.8% | +41.9% | -148.0% | +53.2% | – | +194.8% | -61.1% | -52.1% | +1,128.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +100.0% | – | |
| – | -99.8% | +187.6% | +28.7% | -88.7% | +103,800.0% | -100.0% | +1,691.7% | -127.4% | – | -150.0% | – | – | |
| – | -194.0% | – | – | +710.3% | +263.2% | -216.1% | – | – | -96.3% | -1,863.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.